Bellicum Pharmaceuticals Inc

NASDAQ:BLCM   1:03:34 PM EDT
2.94
-0.05 (-1.67%)
Earnings Announcements

Bellicum Reports Second Quarter 2021 Financial Results And Provides Operational Update

Published: 08/12/2021 22:11 GMT
Bellicum Pharmaceuticals Inc (BLCM) - Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update.
Bellicum Pharmaceuticals Inc- Qtrly Loss per Share $0.22.
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$0.85

Next Quarter Revenue Guidance is expected to be $0.3 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.